Test Price
2,800 AED✅ Home Collection Available
APOC2 Gene Apolipoprotein C-II Deficiency Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين APOC2 لنقص صميم البروتين الشحمي C-II في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified NGS, ensuring definitive detection of all APOC2 gene mutations.
- Premium Logistics: Hospital‑grade cold‑chain home collection across UAE, VIP mobile phlebotomy, and strict sample integrity from vein to sequencer.
- Clinical Guidance: Telephonic post‑test clinical guidance by DHA‑licensed specialists for result interpretation and next‑step planning.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731 – fast pre‑approval for most UAE insurers.
الملخص التنفيذي: حساسية تشخيصية بنسبة 99.9% عبر تحليل التسلسل الجيني من الجيل التالي (NGS) المعتمد من ISO 9001:2015 للكشف القاطع عن طفرات جين APOC2 المسبّبة لنقص صميم البروتين الشحمي C-II. يشمل جمع العينات منزلياً وفق سلسلة تبريد معتمدة، وخدمة الفصد المتنقل لكبار الشخصيات، وإرشادات سريرية هاتفية بعد الفحص. التحقق من التأمين مباشرة عبر واتساب: +971545488731.
Comprehensive Genetic Insight for Fatty‑Acid‑Binding Disorder
The APOC2 genetic test uses Next‑Generation Sequencing (NGS) to identify pathogenic variants in the APOC2 gene that cause Apolipoprotein C‑II deficiency—a rare metabolic disorder leading to severe hypertriglyceridemia, recurrent pancreatitis, and accelerated cardiovascular risk. This definitive DNA analysis enables accurate diagnosis, family cascade screening, and tailored lipid management in accordance with 2026 DHA cardiometabolic guidelines.
| Feature | Our APOC2 NGS Test | Closest Alternative (Targeted Genotyping) |
|---|---|---|
| Methodology | Full‑gene NGS (all exons, splice sites, and regulatory regions) | Limited mutation panel (only common hot‑spots) |
| Diagnostic Sensitivity | >99.9% (captures novel variants) | ~70% (misses rare/private mutations) |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks (often sent abroad) |
| Accreditation | ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139), DHA Licensed | Limited QA/QC oversight |
| Price (AED) | 2,800 | 2,200–3,500 (variable cost) |
Physician Insight & Safety Protocol
“As a DHA‑licensed clinical pathologist, I reassure every patient that an APOC2 result is a roadmap, not a verdict. This test can pinpoint the exact genetic cause of dangerously high triglycerides, but it must be interpreted alongside your full lipid profile and family history. I urge you to never stop prescribed fibrates or omega‑3 therapy without a thorough consultation—true care is a partnership between laboratory precision and clinical wisdom.”
— Dr. PRABHAKAR REDDY, DHA License: 61713011, Clinical Pathologist
⚠️ Medication Warning: Do not discontinue any prescribed lipid‑lowering medication or insulin regimen without consulting your treating physician. Abrupt cessation can provoke acute pancreatitis.
Patient Safety Exclusion Criteria & ER Red Flags
- If you are currently suffering from acute pancreatitis (severe abdominal pain, vomiting), seek emergency care immediately—do not rely solely on genetic testing.
- Minors (under 18) require a legal guardian’s signed consent and a pre‑test genetic counselling session in compliance with the UAE Consumer Data Security Law 2026.
- Pregnant women should inform their doctor; while the test is safe, anxiety management is essential.
- Individuals unable to provide informed consent or with unstable medical conditions should postpone elective genetic testing.
🚨 ER Red Flags: Sudden onset of intense abdominal pain radiating to the back, nausea, vomiting, fever, or yellowish fatty deposits on the skin (eruptive xanthomas) – visit the nearest emergency department immediately.
Patient FAQ & Clinical Guidance
Q: What is the APOC2 gene test used for?
Snippet Answer: This precise genetic detects all known APOC2 mutations to accurately diagnose Apolipoprotein C‑II deficiency. It is indicated for individuals with severe hypertriglyceridemia (>885 mg/dL), recurrent pancreatitis, or a family history of unexplained lipid disorders, allowing definitive molecular confirmation and differentiation from other familial hyperlipidemias.
س: ما فائدة تحليل جين APOC2؟
الإجابة المقتضبة: يكشف هذا التحليل الجيني الدقيق جميع طفرات جين APOC2 المعروفة لتشخيص نقص صميم البروتين الشحمي C‑II بدقة. يُوصى به لمن يعانون من فرط ثلاثي غليسيريد الدم الشديد، أو التهاب البنكرياس المتكرر، أو التاريخ العائلي لاضطرابات الدهون.
Q: How does the NGS method ensure high accuracy and what sample is required?
Snippet Answer: NGS technology reads every base of the APOC2 gene multiple times (high coverage) achieving >99.9% sensitivity. A simple blood sample (whole blood, extracted DNA, or a one‑drop FTA card) is collected by our mobile phlebotomy team and transported in ISO‑certified cold‑chain logistics to prevent degradation.
س: كيف تضمن تقنية NGS دقة عالية وما هي العينة المطلوبة؟
الإجابة المقتضبة: تقرأ تقنية الجيل التالي (NGS) كل قاعدة من جين APOC2 عدة مرات (تغطية عالية) محققة حساسية تتجاوز 99.9%. يكفي أخذ عينة دم (دم كامل، أو DNA مستخلص، أو بقعة دم على بطاقة FTA) عن طريق فريق الفصد المتنقل، وتُنقل ضمن سلسلة تبريد معتمدة من ISO.
Q: Are the results confidential and compliant with UAE data‑protection laws?
Snippet Answer: Absolutely; all genetic data is anonymized and protected under the UAE Personal Data Protection Law (PDPL) and stored in encrypted servers. Your identifiable information is never shared without explicit written consent, and reports are released only to you or your authorized physician.
س: هل النتائج سرية ومتوافقة مع قوانين حماية البيانات في الإمارات؟
الإجابة المقتضبة: بالتأكيد؛ تُشفّر جميع البيانات الجينية وتُخزّن وفقاً لقانون حماية البيانات الشخصية الإماراتي (PDPL) في خوادم محمية. لا تُشارك معلوماتك الشخصية أبداً دون موافقتك الخطية، ولا تُسلّم التقارير إلا لك أو لطبيبك المُفوّض.
This service is performed in strict adherence to Federal Decree‑Law No. 41 of 2024 (Art. 87) on Medical Liability, the UAE Consumer Data Security Law 2026 for minors’ genetic testing, and the Personal Data Protection Law. Facility License No. 9834453. ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139).
All clinical content reviewed by Dr. Prabhakar Reddy, DHA 61713011. Last updated 2026.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians